Crinetics Pharmaceuticals (CRNX) Work In Process (2025 - 2026)
Crinetics Pharmaceuticals' (CRNX) quarterly Work In Process came in at $3.0 million in Q1 2026, up 51.45% quarter-over-quarter from $2.0 million in Q4 2025.
Crinetics Pharmaceuticals (CRNX) Work In Process (2025 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Work In Process history runs 2 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Work In Process changed N/A year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.0 million, changed N/A from the prior year.
- Work In Process rose to $3.0 million in Q1 2026 per CRNX's latest filing, from $2.0 million in the prior quarter.
- Across five years, Work In Process topped out at $3.0 million in Q1 2026 and bottomed at $2.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.74 Bn | 7.44 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 2.00 Mn |